Qaytona is free while it's in beta — Get started

Ingredients

Kava

Piper methysticum · Kava Kava · Kavalactones

Snapshot

IndicationsContraindications
  • Anxiety relief1–3
  • Generalized anxiety disorder1–3
  • Nervous tension and restlessness4
  • Stress reduction5
  • Liver or kidney disease6
  • Sedative medication use6
  • Active alcohol use7
  • Pregnancy or breastfeeding7

Kava (Piper methysticum) is a Pacific Island root extract whose active compounds, the kavalactones, produce anxiolytic and sedative effects via gamma-aminobutyric acid (GABA) receptor potentiation and monoamine modulation7. It is taken primarily for anxiety relief and, secondarily, for stress and sleep, by patients seeking a non-pharmaceutical anxiolytic5. Practitioners considering it will encounter a safety profile dominated by rare but serious hepatotoxicity and a clinically meaningful dependence signal.

Randomized controlled trial (RCT) and meta-analysis evidence supports short-term anxiolytic activity against placebo8, 9. A 16-week double-blind RCT in diagnosed generalized anxiety disorder (GAD) found no significant difference from placebo, and a global clinical guideline taskforce did not recommend kava for GAD1, 10. In a 2025 systematic review examining kava consumption across social, economic, and health domains, the roles of kava in both liver toxicity and anxiety reduction were judged to remain unclear, underscoring the need for larger trials11. Over 400 products listing kava are available in the United States as powders, capsules, and liquids; see Form comparison.

The most consequential contraindication is pre-existing liver disease: LiverTox rates kava a well-established cause of clinically apparent liver injury, with cases ranging from transient enzyme elevation to fulminant hepatic failure requiring transplantation12. The National Center for Complementary and Integrative Health (NCCIH) notes that concurrent alcohol and sedative use compounds both hepatotoxic and sedation risk, requiring practitioner coordination rather than casual avoidance7.

Last updated October 7, 2026. Read how we make monographs.

In the full monograph

73 sources, 58 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.pubmed.ncbi.nlm.nih.govSarris, Byrne, Bousman et al. · The Australian and New Zealand journal of psychiatry · 2020 · Pubmed
  2. 2Kava for Generalized Anxiety Disorder: A Review of Current Evidence.pubmed.ncbi.nlm.nih.govOoi, Henderson, Pak · Journal of alternative and complementary medicine (New York, N.Y.) · 2018 · Pubmed
  3. 3The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.pubmed.ncbi.nlm.nih.govSarris, Kavanagh, Byrne et al. · Psychopharmacology · 2009 · Pubmed
  4. 4Kava (Piper methysticum) Extract for the Treatment of Nervous Anxiety, Tension and Restlessness.pubmed.ncbi.nlm.nih.govKuchta, Hladikova, Thomsen et al. · Drug research · 2021 · Pubmed
  5. 5Kava: a comprehensive review of efficacy, safety, and psychopharmacology.pubmed.ncbi.nlm.nih.govSarris, LaPorte, Schweitzer · The Australian and New Zealand journal of psychiatry · 2011 · Pubmed
  6. 6MSKCCmskcc.orgMemorial Sloan Kettering — About Herbs, Botanicals & Other Products
  7. 7NCCIHnccih.nih.govNational Center for Complementary and Integrative Health
  8. 8Kava extract for treating anxiety.pubmed.ncbi.nlm.nih.govEdzard, Ernst, Pittler · The Cochrane database of systematic reviews · 2003 · Pubmed
  9. 9The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava.pubmed.ncbi.nlm.nih.govWhite · Journal of clinical pharmacology · 2018 · Pubmed
  10. 10Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.pubmed.ncbi.nlm.nih.govSarris, Ravindran, Yatham et al. · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2022 · Pubmed
  11. 11Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations.pubmed.ncbi.nlm.nih.govEconomidis, Lynch, Taylor et al. · Drug and alcohol review · 2025 · Pubmed
  12. 12NIH LiverToxncbi.nlm.nih.govLiverTox, the National Institutes of Health review of liver injury caused by drugs and supplements, with its likelihood score (National Institute of Diabetes and Digestive and Kidney Diseases)